MetaADEDB 2.0 @ LMMD
Felbinac
(QRZAKQDHEVVFRX-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)Cc1ccc(cc1)c1ccccc1
Type(s)
Experimental
ATC code(s)
M02AA08
Molecular Formula:
C14H12O2
Molecular Weight:
212.244
Log P:
2.9807
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
1
TPSA:
37.3
CAS Number(s):
5728-52-9
Synonym(s)
1.
Felbinac
External Link(s)
PubChem Compound3332
BindingDB223312
ChEBI31597
CHEMBLCHEMBL413965
DrugBankDB07477
DrugCentral1141
KEGGdr:D01675
Therapeutic Target DatabaseD0Y7EM
ZINC2318
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2Acoustic NeuromaOFFSIDES
3Activities of daily living impairedOFFSIDES
4Acute bronchitisOFFSIDES
5Adrenal atrophyOFFSIDES
6Alanine Aminotransferase IncreasedOFFSIDES
7Alanine aminotransferase abnormalOFFSIDES
8Altered state of consciousnessOFFSIDES
9AnorexiaOFFSIDES
10ApathyOFFSIDES
11AphagiaOFFSIDES
12AscitesOFFSIDES
13AsterixisOFFSIDES
14AuraOFFSIDES
15Band neutrophil percentage increasedOFFSIDES
16Biliary tract infectionOFFSIDES
17Blood alkaline phosphatase increasedOFFSIDES
18Blood cholesterolOFFSIDES
19Blood lactate dehydrogenase abnormalOFFSIDES
20Blood lactate dehydrogenase increasedOFFSIDES
21Blood pressure immeasurableOFFSIDES
22Blood urea increasedOFFSIDES
23Blood urine presentOFFSIDES
24Brain ContusionOFFSIDES
25BronchiectasisOFFSIDES
26BronchopneumoniaOFFSIDES
27Bulbar palsyOFFSIDES
28Cancer PainOFFSIDES
29Cardiac HypertrophyOFFSIDES
30CellulitisOFFSIDES
31Chronic active hepatitisOFFSIDES
32Cold sweatOFFSIDES
33Concomitant disease progressionOFFSIDES
34Contact DermatitisOFFSIDES
35Coronary angioplastyOFFSIDES
36CraniotomyOFFSIDES
37CyanosisOFFSIDES
38DiabetesOFFSIDES
39DiarrheaOFFSIDES
40Diffuse Large B-Cell LymphomaOFFSIDES
41Disease ProgressionOFFSIDES
42Disseminated Intravascular CoagulationOFFSIDES
43Duodenal UlcerOFFSIDES
44Ejection Fraction DecreasedOFFSIDES
45Erythema MultiformeOFFSIDES
46Foaming at mouthOFFSIDES
47Gamma-Glutamyltransferase IncreasedOFFSIDES
48GlaucomaOFFSIDES
49GlobulinuriaOFFSIDES
50GlossitisOFFSIDES
51Hepatitis BOFFSIDES
52HydrocephalusOFFSIDES
53IleitisOFFSIDES
54Influenza serology positiveOFFSIDES
55Intracranial AneurysmOFFSIDES
56Left Ventricular HypertrophyOFFSIDES
57Leukopenia neonatalOFFSIDES
58Lymphocyte percentage decreasedOFFSIDES
59MonoplegiaOFFSIDES
60Muscle WeaknessOFFSIDES
61Muscle abscessOFFSIDES
62Musculoskeletal stiffnessOFFSIDES
63NasopharyngitisOFFSIDES
64Neutrophil count decreasedOFFSIDES
65Oropharyngeal painOFFSIDES
66OsteosclerosisOFFSIDES
67PROTHROMBIN TIMEOFFSIDES
68Pancreatic enzymes increasedOFFSIDES
69PeriarthritisOFFSIDES
70PeritonitisOFFSIDES
71PleurisyOFFSIDES
72Pneumocystis jiroveci pneumoniaOFFSIDES
73Protein total decreasedOFFSIDES
74Pulmonary InfarctionOFFSIDES
75PurulenceOFFSIDES
76QuadriplegiaOFFSIDES
77Ruptured cerebral aneurysmOFFSIDES
78SarcoidosisOFFSIDES
79Septic ShockOFFSIDES
80SequestrectomyOFFSIDES
81Shunt malfunctionOFFSIDES
82Sudden onset of sleepOFFSIDES
83Upper respiratory tract inflammationOFFSIDES
84VasospasmOFFSIDES
85prostatitisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.